Differential Impacts of APRIL and APRIL/BAFF Inhibition on Immune Populations: Implications for IgA Nephropathy Treatment and Protective Immunity
June 5, 2025 | 62nd ERA Congress
Differential Impacts of APRIL and APRIL/BAFF Inhibition on Immune Populations: Implications for IgA Nephropathy Treatment and Protective Immunity
Preclinical Development of VIS171 – A Novel Modified IL-2 Safely and Selectively Upregulates Regulatory T Cells to Treat Autoimmune Diseases
September 6, 2024 | Promise of Interleukin-2 Therapy Conference
Preclinical Development of VIS171 – A Novel Modified IL-2 Safely and Selectively Upregulates Regulatory T Cells to Treat Autoimmune Diseases
Modified-IL-2 (VIS171) to Preferentially Induce Regulatory T Cells in Nonhuman Primates
September 6, 2024 | Promise of Interleukin-2 Therapy Conference
Modified-IL-2 (VIS171) to Preferentially Induce Regulatory T Cells in Nonhuman Primates
Tissue-resident ST2+ regulatory T cells promote cardiac transplant tolerance induced by a mutein IL-2
June 2, 2024 | American Transplant Congress
Tissue-resident ST2+ regulatory T cells promote cardiac transplant tolerance induced by a mutein IL-2
Sibeprenlimab in patients with IgA nephropathy: a Phase 2 trial
November 2, 2023 | American Society of Nephrology (ASN) Kidney Week
Sibeprenlimab in patients with IgA nephropathy: a Phase 2 trial
COVID Vaccine Responses During Sibeprenlimab Treatment of IgA Nephropathy (IgAN): A Preliminary Analysis
June 15, 2023 | 60th ERA Congress
COVID Vaccine Responses During Sibeprenlimab Treatment of IgA Nephropathy (IgAN): A Preliminary Analysis
Strategies For Development Of Interleukin-2 Therapy In Transplant Recipients: What Works And What Doesn’t
June 3, 2023 | American Transplant Congress
Strategies For Development Of Interleukin-2 Therapy In Transplant Recipients: What Works And What Doesn’t
A Novel IL-2 Mutein Induces Regulatory T Cell-Rich Microenvironment and Leads to Alloantigen-Specific Graft Acceptance
June 3, 2023 | American Transplant Congress
A Novel IL-2 Mutein Induces Regulatory T Cell-Rich Microenvironment and Leads to Alloantigen-Specific Graft Acceptance
Selective Regulatory T-Cell Expansion by A Novel IL-2 Mutein in Murine Transplant and Humanized NSG Models
June 3, 2023 | American Transplant Congress 2023
Selective Regulatory T-Cell Expansion by A Novel IL-2 Mutein in Murine Transplant and Humanized NSG Models
VIS954 is a Potent Anti-C5aR1 Antibody for the Treatment of ANCA-Associated Vasculitis
May 26, 2023 | 15th International Conference on Complement Therapeutics



